Garikipati Venkata N S, Kishore Raj
Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, MERB-953, 3500 N Broad Street, Philadelphia, PA, 19140, USA.
Department of Pharmacology, Temple University, Philadelphia, PA, 19140, USA.
Methods Mol Biol. 2017;1553:85-89. doi: 10.1007/978-1-4939-6756-8_7.
Bone marrow endothelial progenitor cells (EPCs) have shown a great promise to promote ischemic tissue neovascularization and to attenuate ischemic injury in a variety of animal models, which led to EPC-based clinical trials that yielded modest but promising results. Some of the variables in the use of EPCs relate to their differential isolation and characterization protocols since the EPC literature does not identify a unique marker for these vascular progenitors. In this chapter, we present step-by-step protocols for the isolation of EPCs, their characterization and culture conditions, and their potential use in basic and clinical research.
骨髓内皮祖细胞(EPCs)在多种动物模型中已显示出促进缺血组织新血管形成和减轻缺血损伤的巨大潜力,这促使了基于EPCs的临床试验,这些试验取得了适度但有前景的结果。使用EPCs时的一些变量与它们不同的分离和鉴定方案有关,因为EPC文献中没有确定这些血管祖细胞的独特标志物。在本章中,我们介绍了分离EPCs的分步方案、它们的鉴定和培养条件,以及它们在基础研究和临床研究中的潜在用途。